KMT2A-Rearranged Acute Lymphoblastic Leukemia in Infants: Current Progress and Challenges

The authors describe the current progress made, as well as the challenges that still lie ahead in terms of drug-related toxicity, the implementation of less toxic agents, acquired drug resistance, central nervous system involvement, and lineage switches in acute lymphoblastic leukemia diagnosed in infants.